Physician

Rajesh H. Kedar, MD

According to 2025 Medicare claims, Rajesh Kedar, MD (NPI: 1659337681) practices internal medicine in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from York, SC. This provider's primary affiliated billing organization is METROLINA MEDICAL ASSOCIATES P (NPI: 1770741696; TIN: 57-1060550) and primary practice location at 29732-5005. Kedar is affiliated with the Aledade 201 National MSSP (ACO ID: A5522), participating under the MSSP model.

Kedar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 436 traditional Medicare patients, billed 18,264 HCPCS/CPT codes, and received $616,498 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,642 prescription claims across 449 beneficiaries totaling $747,856 in drug costs, led by Eliquis (Apixaban). DME data shows 499 claims. Open Payments data shows 131 records totaling $2,199. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $822,735 to $616,498. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and declined steadily, from $56,124 to $25,389.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	885	25,655	$822,735
2016	700	20,585	$660,279
2017	668	19,698	$644,096
2018	648	19,599	$591,585
2019	573	17,563	$487,757
2020	515	13,174	$352,408
2021	473	11,872	$365,323
2022	425	11,229	$349,118
2023	426	10,780	$365,634
2024	436	18,264	$616,498

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	747	14,152	$960,436
2016	715	13,371	$1,025,023
2017	773	12,726	$1,101,846
2018	780	11,680	$1,255,399
2019	736	10,468	$1,378,904
2020	609	6,315	$761,326
2021	389	4,650	$617,774
2022	351	4,657	$571,992
2023	449	5,649	$727,956
2024	449	5,642	$747,856

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	571	1,429	$60,563
2016	518	1,410	$41,475
2017	440	1,176	$29,320
2018	388	1,211	$31,425
2019	389	952	$21,519
2020	252	664	$18,383
2021	152	452	$11,769
2022	114	407	$10,816
2023	111	410	$13,166
2024	142	499	$19,601

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	372	1,488	$88
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	358	1,055	$12
36415	Insertion of needle into vein for collection of blood sample	342	809	$9
80048	Blood test, basic group of blood chemicals (calcium, total)	328	682	$8
80076	Liver function blood test panel	326	661	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	62	4,440	$86,009
Ozempic	Semaglutide	70	2,736	$82,460
Mounjaro	Tirzepatide	66	2,130	$79,999
Repatha Sureclick	Evolocumab	38	2,408	$46,403
Jardiance	Empagliflozin	45	2,105	$38,529

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7031	Face mask interface, replacement for full face mask, each	N	13	32	$2,749
A7030	Full face mask used with positive airway pressure device, each	N	13	32	$2,554
E0601	Continuous positive airway pressure (cpap) device	Y	12	81	$2,389
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	11	$2,382
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	29	$1,866

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	131	$2,199	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rajesh H. Kedar, MD?

Tedicare shows public-source Medicare data for Rajesh H. Kedar, MD (NPI 1659337681), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rajesh H. Kedar, MD have ACO affiliation data?

Rajesh H. Kedar, MD is shown with ACO affiliation data for Aledade 201 National MSSP (MSSP, ACO ID A5522).

What billing organization is linked to Rajesh H. Kedar, MD?

Rajesh H. Kedar, MD is linked to METROLINA MEDICAL ASSOCIATES P (billing NPI 1770741696) in the available physician profile data.

Does Rajesh H. Kedar, MD have Open Payments data?

Rajesh H. Kedar, MD has 131 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.